跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,917 条关于
“dark borosilicate contrast agent”
全部
11,917
临床试验
7,245
药物
734
机构
71
资讯
3,867
7个月前
New Dark Borosilicate Contrast Agent Shows Promise for Enhanced CT Imaging of Bowel Pathologies
11个月前
FDA Approves First Iron-Based Contrast Agent for Brain MRI Imaging
去年
Bayer Submits Low-Dose MRI Contrast Agent Gadoquatrane for Global Regulatory Approval
9个月前
Bayer's Low-Dose MRI Contrast Agent Gadoquatrane Shows Promise in Pediatric Study
去年
Bayer to Showcase Advanced Radiology Portfolio and Novel Contrast Agent at ECR 2025
4个月前
GE HealthCare Doses First Patient in Phase 2/3 Trial of Manganese-Based MRI Contrast Agent
11个月前
FDA Grants Fast Track Designation to Novel Ultrasound Contrast Agent ASI-02 for Cardiac Imaging
去年
Fresenius Kabi Launches First Generic Iodixanol Contrast Agent in Canada, Addressing Critical Supply Shortages
去年
FDA Clears IND for Agitated Solutions' Novel Cardiac Contrast Agent, Advancing to Phase 3 Trials
3个月前
Bayer's AMBELVIST® (gadoquatrane) Receives FDA Approval as Lowest-Dose Macrocyclic Gadolinium-Based Contrast Agent for MRI
第 1 页，共 387 页
上一页
下一页
